Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale.
Saved in:
| Title: | Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale. |
|---|---|
| Authors: | Del Re M; Departmental Faculty of Medicine, Saint Camillus International University of Health and Medical Sciences, Rome, Italy.; Fondazione Policlinico Universitario IRCCS Agostino Gemelli, Rome, Italy., Inglese E; Unit of Clinical Chemistry, ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy., Bria E; Fondazione Policlinico Universitario IRCCS Agostino Gemelli, Rome, Italy.; Università Cattolica del Sacro Cuore, Rome, Italy., Blok EJ; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Curigliano G; Division of Development of New Drugs for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan 'La Statale', 7, Via Festa del Perdono, 20122, Milan, Italy., Danesi R; Department of Oncology and Hemato-Oncology, University of Milan 'La Statale', 7, Via Festa del Perdono, 20122, Milan, Italy. romano.danesi@unimi.it. |
| Source: | Drugs [Drugs] 2026 Jun; Vol. 86 (6), pp. 871-885. Date of Electronic Publication: 2026 Apr 03. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41931218 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Del+Re+M%22">Del Re M</searchLink>; Departmental Faculty of Medicine, Saint Camillus International University of Health and Medical Sciences, Rome, Italy.; Fondazione Policlinico Universitario IRCCS Agostino Gemelli, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Inglese+E%22">Inglese E</searchLink>; Unit of Clinical Chemistry, ASST Grande Ospedale Metropolitano, Niguarda, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Bria+E%22">Bria E</searchLink>; Fondazione Policlinico Universitario IRCCS Agostino Gemelli, Rome, Italy.; Università Cattolica del Sacro Cuore, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Blok+EJ%22">Blok EJ</searchLink>; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mathijssen+RHJ%22">Mathijssen RHJ</searchLink>; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Division of Development of New Drugs for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan 'La Statale', 7, Via Festa del Perdono, 20122, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Danesi+R%22">Danesi R</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan 'La Statale', 7, Via Festa del Perdono, 20122, Milan, Italy. romano.danesi@unimi.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227600076%22">Drugs</searchLink> [Drugs] 2026 Jun; Vol. 86 (6), pp. 871-885. <i>Date of Electronic Publication: </i>2026 Apr 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>7600076 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1950 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200126667%22">00126667 </searchLink><i>NLM ISO Abbreviation: </i>Drugs <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41931218 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40265-026-02289-y Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 871 Titles: – TitleFull: Sequential Use of Trastuzumab Deruxtecan and Sacituzumab Govitecan in Patients with Breast Cancer: A Pharmacological Approach to Support the Clinical Rationale. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Del Re M – PersonEntity: Name: NameFull: Inglese E – PersonEntity: Name: NameFull: Bria E – PersonEntity: Name: NameFull: Blok EJ – PersonEntity: Name: NameFull: Mathijssen RHJ – PersonEntity: Name: NameFull: Curigliano G – PersonEntity: Name: NameFull: Danesi R IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1179-1950 Numbering: – Type: volume Value: 86 – Type: issue Value: 6 Titles: – TitleFull: Drugs Type: main |
| ResultId | 1 |
